Cite
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
MLA
Ryo Wada, et al. “Pretreatment AKR1B10 Expression Predicts the Risk of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication.” World Journal of Gastroenterology, vol. 22, no. 33, Sept. 2016, pp. 7569–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7bd899eed8828e5310b3f15ed4cfca1c&authtype=sso&custid=ns315887.
APA
Ryo Wada, Nozomi Amano, Hironori Tsuzura, Takafumi Ichida, Katsuyori Iijima, Katsuharu Hirano, Akihito Nagahara, Sumio Watanabe, Yutaka Narita, Sho Sato, Ayato Murata, Yuji Shimada, Yoshio Kanemitsu, Takuya Genda, & Shunsuke Sato. (2016). Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World Journal of Gastroenterology, 22(33), 7569–7578.
Chicago
Ryo Wada, Nozomi Amano, Hironori Tsuzura, Takafumi Ichida, Katsuyori Iijima, Katsuharu Hirano, Akihito Nagahara, et al. 2016. “Pretreatment AKR1B10 Expression Predicts the Risk of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication.” World Journal of Gastroenterology 22 (33): 7569–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7bd899eed8828e5310b3f15ed4cfca1c&authtype=sso&custid=ns315887.